Import 300K bottles of generic Entresto in August & 2,200 kg of the blockbuster heart-failure drug’s active ingredient in December, and what do you get? A @Novartis suit seeking damages for @MSNLabs' alleged infringement of a recently revived patent. https://t.co/EaQPvBdVPw

Thanks for the shout-out, @cmorten2! And thanks to Chris Morten (of @ColumbiaLaw), @PrEP4AllNow, @TAGTeam_Tweets & @reshmagar, each of whom shared time and energy discussing the basis for their perspectives on @HHSGov's settlement last week w/ @GileadSciences on PrEP drugs.

From the SIGN HERE; NO, REALLY Dept.🖋️: @AstellasUS can’t enforce a patent-infringement settlement with @MSNLabs over a generic version of the overactive-bladder drug Myrbetriq because the deal was never signed, a federal judge ruled. https://t.co/EQ6L9PvNg0

NEW: @Neurocrine said in a federal lawsuit that @Spruce_Bio is threatening patent litigation over $NBIX's new rare disease drug Crenessity due to a “desperate need for cash." Neurocrine seeks to void $SPRB's “impermissibly overbroad” patent. https://t.co/NvkRvL2toT

NEW: @Novartis asked two federal courts to block @MSNLabs’ generic Entresto after a key patent’s revival and to require the @US_FDA to enforce pediatric-exclusivity rights for $NOVN's blockbuster heart drug. https://t.co/1oKYnUs3qx

.@EchoStar's @Dish unit asked the US Supreme Court to review whether courts can require attorneys to pay legal fees in exceptionally frivolous patent cases, part of a dispute over DVR technology. https://t.co/bwvpMZW17s

NEW: @BlueAllele stole @IntelliaTx’s pioneering gene-editing tech for inserting healthy DNA into genes to enhance genetic-disease treatments and falsely claimed inventorship of patents central to treating genetic disorders, $NTLA said in a court filing. https://t.co/loAjuNrUup

NEW: @BostonDynamics settled 2 suits alleging @GhostRobotics copied patented tech to build its robotic dogs. BD sued Philly's GR in 11/2022 & 2/2024 alleging its Vision 60 & Spirit 40 products infringe patents. Jury trial in 1st case had been set for Feb. https://t.co/XePT42rTGE

NEW: @AcuitasTx asked a federal court to find the Covid-19 vaccine Comirnaty doesn’t infringe five patents at issue in @GSK’s separate lawsuit seeking a share of the billions of dollars Acuitas’ partners @Pfizer and @BioNTech_Group have made from it. https://t.co/VWrIoGMh3d

Innovative Health Sciences LLC built its Insignis syringe infusion system using insider knowledge from a former @KoruMedical executive, infringing $KRMD patent for safely controlling the flow rate of therapeutic fluids to patients, a federal lawsuit said. https://t.co/slRj60Xc1P

NEW: @Pfizer asked a federal court in Delaware to block copies of blockbuster arthritis drug Xeljanz proposed by @Alkem_Lab that it said infringe a patent expiring this year. It's the only Orange Book-listed patent for the 5- & 10-mg tablet formulations. https://t.co/0wJW2aEU0F

Five @PurduePharma patents covering an abuse-resistant OxyContin formulation that reduces the opiod’s toxicity are invalid, a Federal Circuit panel said. It affirmed a Delaware district judge's voiding of patents in suit over copy by Intas' Accord unit. https://t.co/xLwmHAWPjt

.@Invitae urged a fed. judge to reject @NateraGenetics’ bid for supplemental damages & an ongoing royalty, after a jury awarded $NTRA $19.4M for infringing patents for personalized cancer-monitoring products. $NVTA, meanwhile, sold most assets to @LabCorp. https://t.co/WQREF17lMB

A federal judge in Delaware upheld @10xGenomics’ $31 million verdict win against @bruker's NanoString Technologies Inc. and blocked sales of its GeoMx spatial-imaging products, but declined to increase the damages. https://t.co/COHQxJg00n

YESTERDAY: @Microsoft’s virtual assistants and AI services (Cortana, Copilot, Azure AI, and Azure OpenAI) infringe nine patents for technology developed by voice software pioneer VoiceBox Technologies, @DialectLLC said in a federal lawsuit. https://t.co/58bmXFCDOD

Five patents for @TevaPharm's ProAir HFA asthma inhaler don’t cover the drug's active ingredient & must be delisted from @US_FDA’s registry of approved drugs, an appeals court ruled. Affirmed @AmnealPharma's June victory in the underlying case. https://t.co/3XArMxCGaw

If you missed our breaker on this doozy of a verdict, here's your chance to catch up: Nippon Shinyaku Co. must pay @Sarepta and the @UWAnews $115.2 million for patent infringement by its Viltepso drug, a federal jury found Friday. https://t.co/38me4pWjxv

@Sarepta @nipponshinyaku Phase 2--on the damages $NPPNY owes $SRPT and the @UWAnews, which exclusively licenses the patent to Sarepta for the treatment of muscular dystrophies--concludes today.

BREAKING: @Sarepta swayed a federal jury to uphold a patent @NipponShinyaku admitted its Viltepso infringes & to void a patent $SRPT conceded its competing genetic therapy for Duchenne muscular dystrophy infringes. $NPPNY beat willful infringement claims. https://t.co/zRkolVeVOZ

NEW: @BATPlc’s R.J. Reynolds Vapor Co. failed to shed a North Carolina jury’s $95.2 million verdict finding its Vuse Alto e-cigarette infringes three @AltriaNews vape-pod patents, as an appeals court rejected Reynolds’ challenge. https://t.co/mhde8h0q7g